Sun Pharmaceutical Industries
About Sun Pharmaceutical Industries
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world. Sun Pharma's global presence is supported by 50 manufacturing facilities spread across 5 continents, R&D centres across the globe and a multi-cultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising about 2,000 scientists and R&D investments of over 7% of annual revenues.
Recent News
Sun Pharma to Acquire Organon for ~$11.75B
Stock Market Highlights: Sensex, Nifty Rebound, Snap Three-Day Losing Streak on IT, Sun Pharma Rally
Sun Pharma to Acquire Organon for $11.75 Billion, Expanding B2B Drug Portfolio
Sun Pharma to Acquire Organon for $11.75 B, Boosting Women’s Health and Biosimilars
Nifty Snaps Three-Day Losing Streak, Climbs 195 Points; Midcaps Lead the Charge